PROSTATE CANCER METASTATIC
Clinical trials for PROSTATE CANCER METASTATIC explained in plain language.
Never miss a new study
Get alerted when new PROSTATE CANCER METASTATIC trials appear
Sign up with your email to follow new studies for PROSTATE CANCER METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug tested for men with spreading prostate cancer
Disease control TerminatedThis early-stage trial tested a new drug called LAE001 for men with advanced prostate cancer that had spread and stopped responding to standard hormone therapy. The study aimed to find a safe dose and see if the drug could help control the cancer. All participants continued their…
Matched conditions: PROSTATE CANCER METASTATIC
Phase: PHASE1, PHASE2 • Sponsor: Laekna Limited • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Could less medicine be just as good? prostate cancer study tests lower doses
Disease control TerminatedThis study aimed to find the lowest effective dose of the prostate cancer drug abiraterone. Researchers tested if taking a lower dose less frequently (like every other day or a few times a week) worked as well as the standard daily dose. The goal was to maintain cancer control wh…
Matched conditions: PROSTATE CANCER METASTATIC
Phase: PHASE1 • Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC